Dental periodontitis and HbA1c levels are more closely connected than many people realise. Periodontitis — a severe form of gum disease involving chronic bacterial infection and inflammation — is associated with impaired blood glucose regulation, and may contribute to elevated HbA1c readings in people with type 2 diabetes. The relationship is bidirectional: poor glycaemic control worsens gum disease, whilst active periodontitis may worsen blood sugar control. This article explores the clinical evidence behind this link, what UK guidance says about dental care for people with diabetes, and how a combined approach to managing both conditions may support better overall health outcomes.

How Periodontitis Affects Blood Sugar Control and HbA1c Levels

Periodontitis promotes systemic inflammation via cytokines such as TNF-α and IL-6, which impair insulin signalling and may raise HbA1c; the relationship is bidirectional, with poor glycaemic control also worsening gum disease.

Have any more questions about this? Message our pharmaceutical team to get more info →

Periodontitis is a severe form of gum disease characterised by chronic bacterial infection and inflammation of the tissues supporting the teeth. Beyond its impact on oral health, there is growing clinical evidence that this persistent inflammatory state is associated with impaired blood glucose regulation, and may contribute to elevated HbA1c — the three-month average measure of blood sugar, expressed primarily in mmol/mol in UK practice.

The proposed mechanism centres on the systemic inflammatory response triggered by periodontal pathogens. When bacteria from infected gum tissue enter the bloodstream, they may stimulate the release of pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These cytokines are thought to impair insulin signalling at the cellular level, promoting a state of insulin resistance. As insulin becomes less effective at facilitating glucose uptake, blood sugar levels may rise, and over time this can be reflected in elevated HbA1c readings.

It is important to note that the relationship between periodontitis and glycaemic control is one of association, supported by growing interventional evidence, rather than proven direct causality. It is also bidirectional. Raised blood glucose itself impairs immune function and alters the composition of oral bacteria, making the gums more susceptible to infection and slowing healing. This creates a self-reinforcing cycle in which:

• Periodontitis is associated with worsened glycaemic control

• Poor glycaemic control is associated with worsened periodontitis

Understanding this cycle is clinically significant because it suggests that addressing gum disease may be one component of a broader strategy to support blood sugar management. However, periodontitis is not the sole driver of HbA1c elevation, and its contribution will vary between individuals depending on disease severity, overall health, and other metabolic factors.

This bidirectional relationship is described in detail in the European Federation of Periodontology (EFP) and International Diabetes Federation (IDF) consensus reports, and is referenced in British Society of Periodontology (BSP) guidance.

The Link Between Gum Disease and Type 2 Diabetes in the UK

People with diabetes have an associated two- to three-fold increased risk of periodontitis, and those with both conditions tend to have higher HbA1c levels than those with diabetes alone, according to EFP/IDF consensus data.

The association between periodontal disease and type 2 diabetes is well established in the medical literature and increasingly recognised within UK clinical practice. According to Diabetes UK, people living with diabetes are associated with a two- to three-fold increased risk of developing periodontitis compared with those without the condition, though the precise magnitude of risk varies across studies and residual confounding cannot be excluded. Conversely, severe gum disease has been identified in epidemiological studies as associated with an increased risk of incident type 2 diabetes in previously healthy individuals, though a causal relationship has not been definitively established.

In the UK, both conditions carry a significant public health burden. NHS Digital Quality and Outcomes Framework (QOF) data and Diabetes UK statistics indicate that over 4 million people in England are living with diagnosed type 2 diabetes, with the total rising when accounting for undiagnosed cases. The Adult Dental Health Survey 2009 found that moderate to severe periodontitis affects a substantial proportion of the UK adult population. The overlap between these two groups is considerable, yet the connection is not always addressed in routine clinical consultations.

Several large-scale epidemiological studies, including data reviewed in the EFP/IDF consensus workshops (2017–2018), have found that individuals with poorly controlled diabetes and concurrent periodontitis tend to have higher HbA1c levels than those with diabetes alone. This suggests that the inflammatory burden of gum disease may add a measurable metabolic load.

Despite this evidence, awareness among patients remains low. Many people with type 2 diabetes may not realise that their oral health could be influencing their blood sugar readings. Equally, dental professionals may not routinely enquire about a patient's diabetes status or HbA1c levels. Bridging this gap between dental and medical care is an important step in improving outcomes for people managing both conditions in the UK.

Can Treating Periodontitis Help Lower Your HbA1c?

Non-surgical periodontal therapy is associated with an average HbA1c reduction of approximately 4–5 mmol/mol over three to six months in people with type 2 diabetes, though it is an adjunctive measure, not a primary intervention.

One of the most clinically relevant questions in this area is whether treating periodontitis can contribute to bringing HbA1c closer to target levels. The evidence, while not yet definitive, is encouraging. A number of randomised controlled trials, systematic reviews, and meta-analyses — including a Cochrane Review on periodontal treatment for glycaemic control in people with diabetes, and meta-analyses published in the Journal of Clinical Periodontology as part of the EFP consensus process — have found that successful non-surgical periodontal therapy (root surface debridement) is associated with a modest but statistically significant reduction in HbA1c.

These analyses suggest an average HbA1c reduction of approximately 4–5 mmol/mol (around 0.4%) over a three- to six-month period in people with type 2 diabetes. It is important to note that this effect is modest, that results vary considerably between studies, and that the benefit may attenuate over time without ongoing periodontal maintenance. The evidence supports non-surgical periodontal therapy as a useful adjunctive measure rather than a primary intervention for glycaemic control.

The proposed mechanism is that by reducing the bacterial load and resolving gingival inflammation, periodontal treatment lowers circulating levels of inflammatory cytokines, thereby improving insulin sensitivity. As the systemic inflammatory burden decreases, the body's response to insulin may improve, supporting better glucose regulation.

It is essential to qualify that there is no official clinical guideline currently recommending periodontal treatment as a standalone intervention for lowering HbA1c. The evidence supports it as a complementary measure alongside — not a replacement for — established diabetes management strategies such as dietary modification, physical activity, and prescribed medication. Patients should not adjust their diabetes medicines without medical advice. The potential metabolic benefits of periodontal treatment are best discussed with both the dental team and the GP or diabetes care team.

NHS Guidance on Dental Care for People With Diabetes

The NHS recommends that people with diabetes attend dental check-ups at an individually determined interval per NICE CG19, inform their dentist of their HbA1c, and maintain thorough daily oral hygiene including interdental cleaning.

The NHS recommends that people living with diabetes attend regular dental check-ups. In line with NICE guideline CG19 (Dental recall), the interval between check-ups should be determined individually by the dentist based on the patient's oral health risk — this can range from three months to 24 months. A fixed six-monthly interval is not current NHS guidance; your dentist will advise the most appropriate recall frequency for your circumstances.

Diabetes increases the risk of a range of oral health complications, including periodontitis, dry mouth (xerostomia), oral thrush, and delayed wound healing following dental procedures.

NICE guideline NG28 (Type 2 diabetes in adults: management) does not currently include specific periodontal treatment targets, but emphasises holistic care and addressing comorbidities that may affect glycaemic control. In England, NHS dental treatment is provided under a banding system: a scale and polish, where clinically indicated, is typically covered under a Band 1 charge, while non-surgical periodontal therapy (root surface debridement) is covered under a Band 2 charge. Dental charging arrangements differ across the devolved nations of the UK; patients in Scotland, Wales, and Northern Ireland should check locally applicable charges.

For people with diabetes, the following dental care recommendations are broadly aligned with NHS and NICE guidance:

• Attend dental check-ups at the interval recommended by your dentist, based on your individual oral health needs

• Inform your dentist of your diabetes diagnosis and current HbA1c level (with your consent), as this helps them assess your risk and tailor treatment

• Maintain thorough daily oral hygiene, including twice-daily brushing with fluoride toothpaste and daily interdental cleaning

• Avoid smoking, which significantly worsens both periodontitis and glycaemic control

• Report any signs of gum disease promptly, including bleeding gums, persistent bad breath, or loose teeth

The NHS also encourages integrated care between dental and medical teams, particularly for patients with complex or poorly controlled diabetes, to ensure that oral health is considered as part of the overall management plan. Further patient-facing information is available on the NHS website under 'Diabetes and your teeth and gums'.

When to See Your Dentist or GP About Gum Disease and Blood Sugar

Contact your dentist promptly for bleeding, swollen, or receding gums; seek same-day urgent care via NHS 111 or A&E for facial swelling, fever, or difficulty swallowing; speak to your GP if HbA1c has risen unexpectedly.

Knowing when to seek professional advice is important for anyone managing diabetes alongside concerns about their oral health. Certain signs and symptoms should prompt a timely appointment with either a dentist or a GP, and in some cases, both.

Contact your dentist promptly if you notice:

• Gums that bleed regularly when brushing or flossing

• Persistent bad breath that does not resolve with good oral hygiene

• Gums that appear red, swollen, or have receded from the teeth

• Teeth that feel loose or have shifted position

• Pain when chewing or sensitivity around the gum line

• Pus or discharge around the teeth or gums

These symptoms may indicate active periodontitis requiring professional intervention. Early treatment is associated with better outcomes, both for oral health and potentially for glycaemic control.

Seek same-day urgent dental assessment — contact NHS 111 or an urgent dental service — if you experience:

• Facial swelling, particularly around the jaw, cheek, or neck

• Fever or feeling generally unwell alongside dental pain

• Difficulty swallowing or breathing

• Rapidly spreading infection

These are signs of a potentially serious dental infection. If you have difficulty breathing or swallowing, go to your nearest A&E department immediately.

Speak to your GP or diabetes care team if:

• Your HbA1c has risen unexpectedly despite adherence to your usual management plan

• You have been diagnosed with periodontitis and wish to discuss whether it may be contributing to your blood sugar levels

• You are experiencing recurrent oral infections, which may signal poorly controlled diabetes

• You are due for your annual diabetes review and wish to raise concerns about your oral health

• You are experiencing persistent hyperglycaemia or other symptoms that may require a review of your diabetes management

There is currently no universal national referral pathway in the UK that automatically links a periodontal diagnosis to a diabetes review, though local integrated care pathways may exist in some areas. Patients may therefore need to raise the connection proactively with their healthcare team. Both your dentist and GP can work together to support a more comprehensive approach to your health.

Managing Periodontitis Alongside Diabetes: A Combined Approach

Optimal management requires coordinated dental and medical care — professional root surface debridement for periodontitis alongside individualised HbA1c targets (typically 48–53 mmol/mol per NICE NG28) and lifestyle optimisation.

Effectively managing both periodontitis and diabetes requires a coordinated strategy that addresses the biological, behavioural, and systemic factors contributing to each condition. Neither can be optimally managed in isolation, and the evidence increasingly supports a combined approach that integrates dental and medical care.

From a dental perspective, the cornerstone of periodontitis management is professional non-surgical periodontal therapy (root surface debridement), which involves the removal of bacterial deposits from below the gum line. This is usually followed by a structured maintenance programme with regular review appointments. In more advanced cases, surgical intervention may be required. Systemic antibiotics are not recommended as a routine first-line treatment for periodontitis; their use is reserved for specific indications such as necrotising periodontal disease, acute spreading infection, or selected cases of advanced or refractory disease, in line with BSP guidance and antimicrobial stewardship principles. For people with diabetes, healing following periodontal treatment may be slower, and more frequent monitoring may be necessary.

From a medical perspective, optimising glycaemic control remains the primary goal. NICE guideline NG28 recommends individualised HbA1c targets, typically 48 mmol/mol for most people with type 2 diabetes managed with lifestyle measures or a single non-hypoglycaemia-associated drug, or 53 mmol/mol where there is a higher risk of hypoglycaemia. HbA1c should be monitored every three to six months until stable, then every six months. Optimising glycaemic control involves:

• Dietary management — reducing refined carbohydrates and maintaining a balanced diet

• Physical activity — regular exercise improves insulin sensitivity

• Medication adherence — taking prescribed antidiabetic agents as directed, and not adjusting medicines without medical advice

• Regular HbA1c monitoring — as recommended by your diabetes care team in line with NICE NG28

• Lifestyle modifications — smoking cessation and alcohol moderation

Patients are encouraged to share relevant health information across their care teams, with their consent. Informing your dentist of your HbA1c level and your GP of any active periodontal disease enables both professionals to make more informed clinical decisions. Some specialist diabetes centres in the UK are beginning to incorporate oral health screening into their review processes, reflecting the growing recognition of this important relationship, as highlighted in the EFP/IDF consensus.

Ultimately, bringing HbA1c closer to target is a multifactorial goal. Treating periodontitis is unlikely to achieve this alone, but as part of a comprehensive, patient-centred management plan, addressing gum disease may offer a meaningful and often overlooked contribution to better blood sugar control.

Frequently Asked Questions